Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infection.

[1]  S. Rivella,et al.  Macrophages support pathological erythropoiesis in Polycythemia Vera and Beta-Thalassemia , 2013, Nature Medicine.

[2]  S. Bailer,et al.  Mouse cytomegalovirus egress protein pM50 interacts with cellular endophilin‐A2 , 2013, Cellular microbiology.

[3]  A. Bergman,et al.  CD169+ macrophages provide a niche promoting erythropoiesis under homeostasis, myeloablation and in JAK2V617F-induced polycythemia vera , 2012, Nature Medicine.

[4]  U. Koszinowski,et al.  Block of Death-Receptor Apoptosis Protects Mouse Cytomegalovirus from Macrophages and Is a Determinant of Virulence in Immunodeficient Hosts , 2012, PLoS pathogens.

[5]  D. Scadden,et al.  The bone marrow at the crossroads of blood and immunity , 2011, Nature Reviews Immunology.

[6]  A. Trumpp,et al.  The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in , 2011, The Journal of experimental medicine.

[7]  M. Merad,et al.  Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche , 2011, The Journal of experimental medicine.

[8]  E. Tortoli,et al.  Detection and molecular characterization of Mycobacterium celatum as a cause of splenitis in a domestic ferret (Mustela putorius furo). , 2011, Journal of comparative pathology.

[9]  M. Caligiuri,et al.  Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.

[10]  S. Jonjić,et al.  Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. , 2010, Journal of Clinical Investigation.

[11]  S. McSorley,et al.  Innate Immune Activation during Salmonella Infection Initiates Extramedullary Erythropoiesis and Splenomegaly , 2010, Journal of Immunology.

[12]  I. Yaniv,et al.  Tumor Necrosis Factor Receptors Support Murine Hematopoietic Progenitor Function in the Early Stages of Engraftment , 2010, Stem cells.

[13]  Nathan C Boles,et al.  Quiescent hematopoietic stem cells are activated by IFNγ in response to chronic infection , 2010, Nature.

[14]  D. Voehringer,et al.  A Spread-Deficient Cytomegalovirus for Assessment of First-Target Cells in Vaccination , 2010, Journal of Virology.

[15]  G. Silvestri,et al.  Abnormalities of Erythropoiesis During HIV-1 Disease: A Longitudinal Analysis , 2009, Journal of acquired immune deficiency syndromes.

[16]  U. V. von Andrian,et al.  Trafficking of Murine Hematopoietic Stem and Progenitor Cells in Health and Vascular Disease , 2009, Microcirculation.

[17]  D. Borjesson,et al.  Diminished Hematopoietic Activity Associated with Alterations in Innate and Adaptive Immunity in a Mouse Model of Human Monocytic Ehrlichiosis , 2009, Infection and Immunity.

[18]  A. Makrigiannis,et al.  Ly49h-Deficient C57BL/6 Mice: A New Mouse Cytomegalovirus-Susceptible Model Remains Resistant to Unrelated Pathogens Controlled by the NK Gene Complex1 , 2008, The Journal of Immunology.

[19]  N. Mohandas,et al.  Erythroblastic islands: niches for erythropoiesis. , 2008, Blood.

[20]  P. Baeuerle,et al.  Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor α-independent mouse model , 2008, Annals of the rheumatic diseases.

[21]  K. Toellner,et al.  Ly49H+ NK Cells Migrate to and Protect Splenic White Pulp Stroma from Murine Cytomegalovirus Infection1 , 2008, The Journal of Immunology.

[22]  P. Gallagher,et al.  Picture of the month. Blueberry muffin baby (extramedullary hematopoiesis) due to congenital cytomegalovirus infection. , 2007, Archives of Pediatrics & Adolescent Medicine.

[23]  David Bryder,et al.  Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. , 2007, Cell stem cell.

[24]  H. Broxmeyer,et al.  A role for natural killer T cells and CD1d molecules in counteracting suppression of hematopoiesis in mice induced by infection with murine cytomegalovirus. , 2007, Experimental hematology.

[25]  S. Smirnov,et al.  Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential. , 2007, Virology.

[26]  Eric Vivier,et al.  Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46 , 2007, Proceedings of the National Academy of Sciences.

[27]  C. Benedict,et al.  Specific Remodeling of Splenic Architecture by Cytomegalovirus , 2006, PLoS pathogens.

[28]  V. Cerundolo,et al.  Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells. , 2005, Blood.

[29]  U. Koszinowski,et al.  Frequent Coinfection of Cells Explains Functional In Vivo Complementation between Cytomegalovirus Variants in the Multiply Infected Host , 2005, Journal of Virology.

[30]  S. Jonjić,et al.  Selective Down-Regulation of the NKG2D Ligand H60 by Mouse Cytomegalovirus m155 Glycoprotein , 2005, Journal of Virology.

[31]  Nancy A. Jenkins,et al.  Simple and highly efficient BAC recombineering using galK selection , 2005, Nucleic acids research.

[32]  H. Virgin,et al.  Natural Killer Cells Utilize both Perforin and Gamma Interferon To Regulate Murine Cytomegalovirus Infection in the Spleen and Liver , 2005, Journal of Virology.

[33]  D. Busch,et al.  NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145 , 2004, The Journal of experimental medicine.

[34]  L. Lanier,et al.  The Cytomegalovirus m155 Gene Product Subverts Natural Killer Cell Antiviral Protection by Disruption of H60–NKG2D Interactions , 2004, The Journal of experimental medicine.

[35]  S. Jonjić,et al.  Gain of Virulence Caused by Loss of a Gene in Murine Cytomegalovirus , 2004, Journal of Virology.

[36]  S. Jonjić,et al.  Pathogenesis of murine cytomegalovirus infection. , 2003, Microbes and infection.

[37]  L. Lanier,et al.  NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules , 2003, The Journal of experimental medicine.

[38]  U. Koszinowski,et al.  Role of Murine Cytomegalovirus US22 Gene Family Members in Replication in Macrophages , 2003, Journal of Virology.

[39]  M. Smyth,et al.  Activation of Natural Killer (NK) T Cells during Murine Cytomegalovirus Infection Enhances the Antiviral Response Mediated by NK Cells , 2003, Journal of Virology.

[40]  B. Torok-Storb,et al.  Cytomegalovirus mediated myelosuppression. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[41]  A. Herbelin,et al.  Ligand‐activated natural killer T lymphocytes promptly produce IL‐3 and GM‐CSF in vivo: relevance to peripheral myeloid recruitment , 2002, European journal of immunology.

[42]  D. Fremont,et al.  Recognition of a virus-encoded ligand by a natural killer cell activation receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  L. Lanier,et al.  Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.

[44]  S. Gea,et al.  Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite , 2002, European journal of immunology.

[45]  C. Alliot,et al.  Spontaneous Splenic Rupture Associated with CMV Infection: Report of a Case and Review , 2001, Scandinavian journal of infectious diseases.

[46]  I. Weissman,et al.  The monoclonal antibody TER‐119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage , 2000, British journal of haematology.

[47]  P. Kaye,et al.  Enhanced Hematopoietic Activity Accompanies Parasite Expansion in the Spleen and Bone Marrow of Mice Infected with Leishmania donovani , 2000, Infection and Immunity.

[48]  J. Maciejewski,et al.  Human cytomegalovirus infection of human hematopoietic progenitor cells. , 1999, Leukemia & lymphoma.

[49]  L. Hültner,et al.  Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. , 1999, Journal of immunology.

[50]  Y. Ikeda,et al.  In vivo disturbance of hematopoiesis in mice persistently infected with murine cytomegalovirus: impairment of stromal cell function. , 1999, Virology.

[51]  W. Hammerschmidt,et al.  Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  P. Angele,et al.  Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes , 1997, Journal of virology.

[53]  R. Welsh,et al.  Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells , 1997, Journal of virology.

[54]  D. Longo,et al.  NK Cells in the Regulation of Hematopoiesis , 1996, Methods.

[55]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[56]  R. Zinkernagel,et al.  Immune response in mice that lack the interferon-gamma receptor. , 1993, Science.

[57]  K. Umehara,et al.  Murine cytomegalovirus infection model in Balb/c mice. 3. Immunoglobulin production during infection. , 1991, The Tokai Journal of Experimental and Clinical Medicine.

[58]  J. Villeval,et al.  Changes in hemopoietic and regulator levels in mice during fatal or nonfatal malarial infections. II. Nonerythroid populations. , 1990, Experimental parasitology.

[59]  N. Rooijen,et al.  Macrophage Subset Repopulation in the Spleen: Differential Kinetics After Liposome‐Mediated Elimination , 1989, Journal of leukocyte biology.

[60]  U. Koszinowski,et al.  Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host , 1988, The Journal of experimental medicine.

[61]  J. Booss,et al.  Immune stimulation, inflammation, and changes in hematopoiesis. Host responses of the murine spleen to infection with cytomegalovirus. , 1981, The American journal of pathology.

[62]  J. Hudson,et al.  Murine cytomegalovirus infection in the spleen and its relationship to immunosuppression , 1981, Infection and immunity.

[63]  S. Achilefu,et al.  Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. , 2009, The Journal of general virology.

[64]  W. Yokoyama,et al.  Cmv1 and natural killer cell responses to murine cytomegalovirus infection. , 2008, Current topics in microbiology and immunology.

[65]  J. Vávrová,et al.  Hematopoietic Recovery after Transplantation CD117+B220- (lacZ+) Bone Marrow Cells in Lethally Irradiated Mice. , 2008, Acta medica.

[66]  P. Angele,et al.  Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma , 2005, Annals of Hematology.

[67]  P. Duarte,et al.  Ruptura espontánea de bazo asociada a infección activa por citomegalovirus , 2003 .